When cancer is found earlier, treatment is more likely to be successful. Too often, diagnosis occurs at later stages, after symptoms have developed and the cancer has spread. This is particularly true of unscreened cancers, and especially so among underserved communities, like racial and ethnic minorities and rural populations.
Shifting diagnoses earlier would have a profound impact on cancer outcomes for all cancer patients.
MCED is a revolutionary new approach to cancer detection. With a simple blood draw, MCED tests can detect dozens of cancers all at once in earlier stages.
As cancer tumors grow, they produce signals that can be detected through these blood tests that combine emerging medical science and information technologies. A number of companies are working to develop and market MCED tests.
MCED has the potential to transform cancer detection so that many more cancers can be detected earlier when they are more treatable. MCED greatly expands the number of cancers that can be screened. Today, screenings are only available for five types of cancer.